Simons Hannah R, Unger Zoe D, Lopez Priscilla M, Kohn Julia E
The authors are with Planned Parenthood Federation of America, New York, NY.
Am J Public Health. 2015 Dec;105(12):2541-8. doi: 10.2105/AJPH.2015.302834. Epub 2015 Oct 15.
We estimated human papillomavirus (HPV) vaccine series completion and examined predictors of completion among adolescents and young adults in a large family planning network.
Our retrospective cohort study of vaccine completion within 12 months and time to completion used electronic health record data from 119 Planned Parenthood health centers in 11 US states for 9648 patients who initiated HPV vaccination between January 2011 and January 2013.
Among vaccine initiators, 29% completed the series within 12 months. Patients who were male, younger than 22 years, or non-Hispanic Black or who had public insurance were less likely to complete within 12 months and completed more slowly than their counterparts. Gender appeared to modify the effect of public versus private insurance on completion (adjusted hazard ratio = 0.76 for women and 0.95 for men; relative excess risk due to interaction = 0.41; 95% confidence interval = 0.09, 0.73).
Completion was low yet similar to previous studies conducted in safety net settings.
我们评估了人乳头瘤病毒（HPV）疫苗系列接种的完成情况，并研究了一个大型计划生育网络中青少年和年轻成年人完成接种的预测因素。
我们对12个月内疫苗接种完成情况及完成时间进行回顾性队列研究，使用了美国11个州119家计划生育健康中心的电子健康记录数据，这些数据来自2011年1月至2013年1月期间开始接种HPV疫苗的9648名患者。
在开始接种疫苗的人群中，29%在12个月内完成了系列接种。男性、年龄小于22岁、非西班牙裔黑人或有公共保险的患者在12个月内完成接种的可能性较小，且完成接种的速度比其他人慢。性别似乎改变了公共保险与私人保险对完成接种的影响（女性调整后风险比=0.76，男性为0.95；交互作用导致的相对超额风险=0.41；95%置信区间=0.09，0.73）。
接种完成率较低，但与之前在安全网环境中进行的研究相似。
